Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B8,7 | Lung | Primary cancer | 2,258 | Tumor/Malignant | 59.5% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__178_B8,8 | Lung | Primary cancer | 3,572 | Tumor/Malignant | 54.8% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__178_B8,9 | Lung | Primary cancer | 2,029 | Tumor/Malignant | 61.1% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_C1,1 | Lung | Primary cancer | 3,156 | Tumor/Malignant | 55.7% | 0.88 | 0.33 |
| NSCLC_38242124__IMC__178_C1,10 | Lung | Primary cancer | 427 | Stromal | 37.7% | 0.94 | 0.15 |
| NSCLC_38242124__IMC__178_C1,13 | Lung | Primary cancer | 2,871 | Tumor/Malignant | 33.0% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__178_C1,14 | Lung | Primary cancer | 820 | Stromal | 31.6% | 0.75 | 0.53 |
| NSCLC_38242124__IMC__178_C1,15 | Lung | Primary cancer | 1,425 | Other | 37.8% | 0.83 | 0.41 |
| NSCLC_38242124__IMC__178_C1,16 | Lung | Primary cancer | 833 | Other | 37.3% | 0.74 | 0.56 |
| NSCLC_38242124__IMC__178_C1,17 | Lung | Primary cancer | 5,784 | Immune | 76.9% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__178_C1,18 | Lung | Primary cancer | 296 | Tumor/Malignant | 54.7% | 0.80 | 0.40 |
| NSCLC_38242124__IMC__178_C1,2 | Lung | Primary cancer | 2,430 | Tumor/Malignant | 37.2% | 0.83 | 0.44 |
| NSCLC_38242124__IMC__178_C1,3 | Lung | Primary cancer | 2,911 | Tumor/Malignant | 45.1% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__178_C1,6 | Lung | Primary cancer | 20 | Other | 90.0% | 0.50 | 0.83 |
| NSCLC_38242124__IMC__178_C1,7 | Lung | Primary cancer | 2,737 | Other | 27.3% | 0.69 | 0.62 |
| NSCLC_38242124__IMC__178_C1,8 | Lung | Primary cancer | 1,107 | Stromal | 46.2% | 0.80 | 0.48 |
| NSCLC_38242124__IMC__178_C1,9 | Lung | Primary cancer | 799 | Stromal | 31.2% | 0.46 | 0.74 |
| NSCLC_38242124__IMC__178_C2,1 | Lung | Primary cancer | 1,847 | Tumor/Malignant | 41.9% | 0.91 | 0.29 |
| NSCLC_38242124__IMC__178_C2,10 | Lung | Primary cancer | 3,482 | Immune | 28.6% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__178_C2,11 | Lung | Primary cancer | 3,801 | Tumor/Malignant | 46.1% | 0.94 | 0.20 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B8,7 | Lung | Primary cancer | 2,258 | Tumor/Malignant | 49.2% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__178_B8,8 | Lung | Primary cancer | 3,572 | Tumor/Malignant | 37.5% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__178_B8,9 | Lung | Primary cancer | 2,029 | Tumor/Malignant | 61.5% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_C1,1 | Lung | Primary cancer | 3,156 | Tumor/Malignant | 39.2% | 0.77 | 0.55 |
| NSCLC_38242124__IMC__178_C1,10 | Lung | Primary cancer | 427 | Stromal | 37.7% | 0.94 | 0.15 |
| NSCLC_38242124__IMC__178_C1,13 | Lung | Primary cancer | 2,871 | Tumor/Malignant | 37.0% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__178_C1,14 | Lung | Primary cancer | 820 | Tumor/Malignant | 26.5% | 0.53 | 0.78 |
| NSCLC_38242124__IMC__178_C1,15 | Lung | Primary cancer | 1,425 | Other | 26.8% | 0.66 | 0.60 |
| NSCLC_38242124__IMC__178_C1,16 | Lung | Primary cancer | 833 | Other | 39.6% | 0.55 | 0.76 |
| NSCLC_38242124__IMC__178_C1,17 | Lung | Primary cancer | 5,784 | Lymphoid | 75.1% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__178_C1,18 | Lung | Primary cancer | 296 | Tumor/Malignant | 54.7% | 0.80 | 0.40 |
| NSCLC_38242124__IMC__178_C1,2 | Lung | Primary cancer | 2,430 | Stromal | 24.0% | 0.76 | 0.51 |
| NSCLC_38242124__IMC__178_C1,3 | Lung | Primary cancer | 2,911 | Tumor/Malignant | 45.6% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__178_C1,6 | Lung | Primary cancer | 20 | Other | 90.0% | 0.50 | 0.83 |
| NSCLC_38242124__IMC__178_C1,7 | Lung | Primary cancer | 2,737 | Other | 23.7% | 0.70 | 0.58 |
| NSCLC_38242124__IMC__178_C1,8 | Lung | Primary cancer | 1,107 | Stromal | 27.4% | 0.90 | 0.38 |
| NSCLC_38242124__IMC__178_C1,9 | Lung | Primary cancer | 799 | Tumor/Malignant | 27.2% | 0.95 | 0.21 |
| NSCLC_38242124__IMC__178_C2,1 | Lung | Primary cancer | 1,847 | Tumor/Malignant | 35.7% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__178_C2,10 | Lung | Primary cancer | 3,482 | Myeloid | 25.6% | 0.80 | 0.50 |
| NSCLC_38242124__IMC__178_C2,11 | Lung | Primary cancer | 3,801 | Tumor/Malignant | 28.9% | 0.76 | 0.63 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B8,7 | Lung | Primary cancer | 2,258 | Tumor/Malignant cell | 65.2% | 0.95 | 0.17 |
| NSCLC_38242124__IMC__178_B8,8 | Lung | Primary cancer | 3,572 | Tumor/Malignant cell | 54.3% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__178_B8,9 | Lung | Primary cancer | 2,029 | Tumor/Malignant cell | 73.6% | 0.96 | 0.11 |
| NSCLC_38242124__IMC__178_C1,1 | Lung | Primary cancer | 3,156 | Tumor/Malignant cell | 52.0% | 0.90 | 0.31 |
| NSCLC_38242124__IMC__178_C1,10 | Lung | Primary cancer | 427 | Fibroblast | 37.7% | 0.94 | 0.15 |
| NSCLC_38242124__IMC__178_C1,13 | Lung | Primary cancer | 2,871 | Tumor/Malignant cell | 52.3% | 0.92 | 0.26 |
| NSCLC_38242124__IMC__178_C1,14 | Lung | Primary cancer | 820 | Fibroblast | 31.0% | 0.71 | 0.63 |
| NSCLC_38242124__IMC__178_C1,15 | Lung | Primary cancer | 1,425 | Other | 42.5% | 0.80 | 0.45 |
| NSCLC_38242124__IMC__178_C1,16 | Lung | Primary cancer | 833 | Other | 39.3% | 0.73 | 0.57 |
| NSCLC_38242124__IMC__178_C1,17 | Lung | Primary cancer | 5,784 | B cell | 75.0% | 0.95 | 0.13 |
| NSCLC_38242124__IMC__178_C1,18 | Lung | Primary cancer | 296 | Tumor/Malignant cell | 54.7% | 0.80 | 0.40 |
| NSCLC_38242124__IMC__178_C1,2 | Lung | Primary cancer | 2,430 | Tumor/Malignant cell | 34.9% | 0.84 | 0.41 |
| NSCLC_38242124__IMC__178_C1,3 | Lung | Primary cancer | 2,911 | Tumor/Malignant cell | 50.8% | 0.92 | 0.24 |
| NSCLC_38242124__IMC__178_C1,6 | Lung | Primary cancer | 20 | Other | 90.0% | 0.50 | 0.83 |
| NSCLC_38242124__IMC__178_C1,7 | Lung | Primary cancer | 2,737 | Other | 26.6% | 0.68 | 0.63 |
| NSCLC_38242124__IMC__178_C1,8 | Lung | Primary cancer | 1,107 | Fibroblast | 40.4% | 0.71 | 0.58 |
| NSCLC_38242124__IMC__178_C1,9 | Lung | Primary cancer | 799 | Tumor/Malignant cell | 41.3% | 0.85 | 0.38 |
| NSCLC_38242124__IMC__178_C2,1 | Lung | Primary cancer | 1,847 | Tumor/Malignant cell | 41.1% | 0.91 | 0.27 |
| NSCLC_38242124__IMC__178_C2,10 | Lung | Primary cancer | 3,482 | Myeloid cell, unspecified | 26.5% | 0.78 | 0.55 |
| NSCLC_38242124__IMC__178_C2,11 | Lung | Primary cancer | 3,801 | Tumor/Malignant cell | 46.5% | 0.94 | 0.23 |